LIfescient, Inc.

A veterinary specialty pharmaceutical company reformulating approved medications into long-acting injectables.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location South San Francisco, CA, USA
  • Currency USD
  • Founded February 2017
  • Employees 2
  • Incorporation Type C-corp
  • Website lifescient.com

Company Summary

Lifescient is developing long-acting injectable medications (LAI) to replace daily dosing in pets. LAIs were approved by the FDA for use in humans, and Lifescient is applying this drug delivery system to veterinary medicine to offer supervision-free medication administration for pets with chronic health needs. LAIs will free pet families from the burden of daily dosing, guarantee prescription compliance, and improve the quality of care.

Team

  • Kamalesh Rao
    CEO

    Kamalesh Rao, the company founder & CEO, was part of a team that developed long acting injectables (LAIs) for use in humans to treat opioid addiction. It occurred to him that this same idea could be applied to pets to replace the demands of daily dosing. He improved on the platform with the use of a biodegradable polymer that is employed in human surgery. He has over 25 years of experience in the development of pharmaceuticals.

  • Renee Sera
    Chief Administrative Officer

    Renee Sera is the Chief Administrative Officer of Lifescient. Before joining the company, she started as a consultant and helped market the company and its products to the public. Renee is a small business entrepreneur, real estate developer and a founding investor. She has experience in marketing, public outreach, and business development.

Advisors

Previous Investors

  • Ted Ianiro
    Unconfirmed
    Renee Sera
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free